Xencor, Inc. ( XNCR) - Key Metrics
XNCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.68 | -$0.29 | -$1.63 | -$1.64 |
| 2026Q1 | $0.06 | -$1.71 | -$0.90 | -$0.91 |
| 2025Q4 | $0.38 | -$0.09 | -$0.70 | -$0.71 |
| 2025Q3 | $0.28 | -$0.08 | -$0.41 | -$0.42 |
| 2025Q2 | $0.59 | -$0.41 | -$0.49 | -$0.49 |
XNCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -13.88 |
| 2026Q1 | 0% | -1.76 |
| 2025Q4 | 0% | -42.53 |
| 2025Q3 | 0% | -36.66 |
| 2025Q2 | 0% | -4.79 |
XNCR
Price: $23.34
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 500400
Ebitda: -14.8 millionMarket Capitalization: 1.6 billion